Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Accounts Payables (2022 - 2023)

Lexeo Therapeutics' Accounts Payables history spans 2 years, with the latest figure at $2.7 million for Q3 2023.

  • For Q3 2023, Accounts Payables changed N/A year-over-year to $2.7 million; the TTM value through Sep 2023 reached $2.7 million, changed N/A, while the annual FY2022 figure was $2.7 million, N/A changed from the prior year.
  • Accounts Payables for Q3 2023 was $2.7 million at Lexeo Therapeutics, down from $2.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.7 million in Q4 2022 and bottomed at $2.7 million in Q3 2023.